Combined treatment of relapse of chronic hepatitis C with high-dose α2b interferon plus ribavirin for 6 or 12 months
- 30 September 2000
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 33 (3), 456-462
- https://doi.org/10.1016/s0168-8278(00)80282-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Chronic Hepatitis C and Interferon Alpha: Conventional and Cumulative Meta-Analyses of Randomized Controlled TrialsAmerican Journal Of Gastroenterology, 1999
- Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon.Digestive Diseases and Sciences, 1999
- Prognosis of chronic hepatitis c: Results of a large, prospective cohort studyHepatology, 1998
- Determinants of outcome of compensated hepatitis C virus-related cirrhosisHepatology, 1998
- Long-term course of interferon-treated chronic hepatitis CJournal of Hepatology, 1998
- Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.Gastroenterology, 1997
- The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysisJournal of Hepatology, 1997
- Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGastroenterology, 1997
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and durationHepatology, 1996
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995